Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry

Authors :: Riccardo Campi
Maria Carmen Mir
José Rubio-Briones
Thomas Amiel
Matthias Heck
Fady Ghali
Estefania Linares
Andrea Minervini
Maximilian C. Kriegmair
U. Capitanio
F. Porpiglia
Ithaar Derweesh
Georgi Guruli
Nicola Pavan
Vital Hevia
S. Van Bruwaene
Michele Marchioni
Selcuk Erdem
Mireia Musquera
A. Antonelli
R. Autorino
C. Palumbo
Eduard Roussel
Tobias Klatte
Source :: European Urology Open Science, Vol 19, Iss, Pp e1274-e1275 (2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: medicine.medical_specialty
business.industry
Urology
Metastatic renal cancer
Medicine
Cytoreductive nephrectomy
business
lcsh:Diseases of the genitourinary system. Urology
lcsh:RC870-923
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282

Tools